Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...oronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.
more
Depression is a leading cause of non-fatal disease burden worldwide, with a lifetime prevalence of 9% among European adult men and 17% among European adult women.
The task at hand requires substantial investments in preventive mental health care, but the potential benefits can be equally rewarding.... After all, mental wellbeing is a key resource for learning, productivity, participation and inclusion. Investing in proactive care to promote, protect and sustain mental health in the population is therefore likely to offer good value for money.
more
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
Laboratory monitoring & evaluation tool Xpert Pre-installation Checklist
Accessed December 2017
for health and nutrition workers in emergency situations for training, practice and reference
Second Edition
AIDS Medicines and diagnostics services
July 2015
Moving towards equity and quality
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.